Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001650664-26-000056
Filing Date
2026-06-05
Accepted
2026-06-05 16:33:02
Documents
1
Period of Report
2026-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1780691579.html 4  
1 FORM 4 wk-form4_1780691579.xml 4 4221
  Complete submission text file 0001650664-26-000056.txt   5611
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address
O'Neill Gilmore Neil (Reporting) CIK: 0001742084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 261069678